Amanote Research

Amanote Research

    RegisterSign In

Erenumab: A Monoclonal Antibody for Migraine Prophylaxis

Prescriber - United Kingdom
doi 10.1002/psb.1750
Full Text
Open PDF
Abstract

Available in full text

Categories
Pharmacology
Date

March 1, 2019

Authors
Steve Chaplin
Publisher

Wiley


Related search

Galcanezumab: A Monoclonal Antibody for Migraine Prophylaxis

Prescriber
Pharmacology
2020English

074 Early Australian Experience With Erenumab for Chronic Migraine

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2019English

Drugs for Migraine Prophylaxis

Clinical Neurology
Neurology
2012English

Migraine Prophylaxis in Adult Patients

Western Journal of Medicine
2000English

Acetazolamide for the Prophylaxis of Migraine in CADASIL: A Preliminary Experience

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2012English

Nutraceutical Preparations in Childhood Migraine Prophylaxis

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2013English

Human Monoclonal Anti-Protective Antigen Antibody for the Low-Dose Post-Exposure Prophylaxis and Treatment of Anthrax

BMC Infectious Diseases
Infectious Diseases
2018English

A Monoclonal Thyroid-Stimulating Antibody

Journal of Clinical Investigation
Medicine
2002English

A Monoclonal Antibody Specific for Mouse Dendritic Cells.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1982English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy